Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Oncocliffe Lynch Syndrome/HNPCC Gene Panel is 14 days.

What are the prerequisites for the test Oncocliffe Lynch Syndrome/HNPCC Gene Panel

  • Patients must have a confirmed diagnosis of Lynch syndrome or suspected hereditary non-polyposis colorectal cancer (HNPCC)
  • Patients must be referred by a healthcare provider
  • Patients must provide a detailed medical history and family history of cancer
  • Patients must not have undergone treatment that could interfere with the accuracy of genetic testing
  • Patients must provide informed consent for genetic testing

What are the measure values for the test Oncocliffe Lynch Syndrome/HNPCC Gene Panel

  1. MLH1 gene mutation analysis
  2. MSH2 gene mutation analysis
  3. MSH6 gene mutation analysis
  4. PMS2 gene mutation analysis
  5. EPCAM gene mutation analysis

What does this test Oncocliffe Lynch Syndrome/HNPCC Gene Panel identify?

  • Oncocliffe Lynch Syndrome/HNPCC Gene Panel identifies mutations in genes associated with Lynch Syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
  • These genes include MLH1, MSH2, MSH6, PMS2, and EPCAM.
  • Individuals with mutations in these genes have an increased risk of developing colorectal cancer, as well as other types of cancer such as endometrial, ovarian, stomach, and urinary tract cancers.
  • Identifying mutations in these genes can help in early detection, screening, and personalized treatment plans for individuals at risk for Lynch Syndrome.

Why is this test Oncocliffe Lynch Syndrome/HNPCC Gene Panel taken?

The Oncocliffe Lynch Syndrome/HNPCC Gene Panel test is taken to identify mutations in genes associated with Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC). Lynch syndrome is an inherited condition that increases the risk of developing colorectal cancer and other types of cancer, such as endometrial, ovarian, and gastric cancer.

Individuals with Lynch syndrome have a higher chance of developing these cancers at a younger age compared to the general population. Identifying mutations in the genes associated with Lynch syndrome can help healthcare providers determine an individual's risk of developing cancer and develop a personalized screening and management plan.

No FAQs available.

Customer Google Rating